UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 237

Sortiert nach

63P Intrahepatic cholangiocarcinoma (iCCA) genomic findings with high versus low tumor mutational burdens

Annals of oncology, 2022-09, Vol.33, p.S569

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy

Annals of oncology, 2019-01, Vol.30 (1), p.68-75

2019

Link zum Volltext

Verfügbarkeit prüfen

Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial

Annals of oncology, 2022-10, Vol.33 (10), p.1061-1070

2022

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer

Annals of oncology, 2019-03, Vol.30 (3), p.431-438

2019

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial

Annals of oncology, 2023-02, Vol.34 (2), p.163-172

2023

Link zum Volltext

Verfügbarkeit prüfen

A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

Annals of oncology, 2015-01, Vol.26 (1), p.205-211

2015

Link zum Volltext

Verfügbarkeit prüfen

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

Annals of oncology, 2017-04, Vol.28 (4), p.868-873

2017

Link zum Volltext

Verfügbarkeit prüfen

External control arms in oncology: current use and future directions

Annals of oncology, 2022-04, Vol.33 (4), p.376-383

2022

Link zum Volltext

Verfügbarkeit prüfen

Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study

Annals of oncology, 2020-07, Vol.31 (7), p.912-920

2020

Link zum Volltext

Verfügbarkeit prüfen

44P Investigation of scorpion venom-derived anticancer peptides inhibition of metastatic cancer cells growth and induction of apoptosis

Annals of oncology, 2021-03, Vol.32, p.S18-S18

2021

Link zum Volltext

Verfügbarkeit prüfen

Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial

Annals of oncology, 2019-11, Vol.30 (11), p.1831-1839

2019

Link zum Volltext

Verfügbarkeit prüfen

585P Fragmentomics early detection assay leading to potential clinical benefits in colorectal cancer

Annals of oncology, 2023-10, Vol.34, p.S426-S426

2023

Link zum Volltext

Verfügbarkeit prüfen

Short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): A planned interim analysis

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii167

2018

Link zum Volltext

Verfügbarkeit prüfen

216P PTCH1 mutation as a potential predictor of immune checkpoint inhibitors in gastrointestinal cancer

Annals of oncology, 2023-10, Vol.34, p.S268-S268

2023

Link zum Volltext

Verfügbarkeit prüfen

246P DNA repair protein RAD51 homolog 1 (RAD51), a potential prognostic biomarker and target for breast cancer

Annals of oncology, 2022-05, Vol.33, p.S235-S236

2022

Link zum Volltext

Verfügbarkeit prüfen

Circular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s

Annals of oncology, 2018-11, Vol.29, p.ix16-ix16

2018

Link zum Volltext

Verfügbarkeit prüfen

1385P Phase II study of neoadjuvant camrelizumab combined with chemoradiation for locally advanced proximal gastric cancer (Neo-PLANET, NCT03631615)

Annals of oncology, 2021-09, Vol.32, p.S1049-S1049

2021

Link zum Volltext

Verfügbarkeit prüfen

5P Clinicopathologic features and genomic profiling of occult breast cancer

Annals of oncology, 2023-11, Vol.34, p.S1469-S1470

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial

Annals of oncology, 2021-02, Vol.32 (2), p.218-228

2021

Link zum Volltext

Verfügbarkeit prüfen

466P Integrated analysis of potential prognosis and differential expression between primary and metastatic foci for COL12A1 in breast cancer

Annals of oncology, 2023-10, Vol.34, p.S377-S377

2023

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies

Annals of oncology, 2017-04, Vol.28 (4), p.733-740

2017

Link zum Volltext

Verfügbarkeit prüfen

Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

Annals of oncology, 2017-09, Vol.28 (9), p.2199-2205

2017

Link zum Volltext

Verfügbarkeit prüfen

358P Anlotinib plus temozolomide for recurrent glioma: A single-center, retrospective study of 30 cases

Annals of oncology, 2021-09, Vol.32, p.S522-S522

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term results of postoperative chemoradiation therapy with capecitabine and oxaliplatin versus capecitabine alone for locally advanced rectal cancer: A randomized, multicenter, phase III trial

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii153

2018

Link zum Volltext

Verfügbarkeit prüfen

1337P Real-world utilization and outcomes of dacomitinib as first-line therapy in Asian patients with advanced EGFR mutation–positive NSCLC: An interim analysis of the ARIA study

Annals of oncology, 2023-10, Vol.34, p.S771-S771

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 237

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Zeitschrift / SerieAnnals Of Oncology

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)

Publikationsform

Artikel
(237)

Sprache

Englisch
(237)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Oncology
(13)
Humans
(12)
Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Female
(7)
Male
(7)
Aged
(6)
Middle Aged
(6)
Adult
(4)
Prognosis
(4)
Aged, 80 And Over
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Disease-Free Survival
(3)
Hematology
(3)
Abstracts
(2)
Anthracyclines - Therapeutic Use
(2)
Biomarkers, Tumor - Genetics
(2)
Chemotherapy, Adjuvant
(2)
Disease Progression
(2)
Follow-Up Studies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

63P Intrahepatic cholangiocarcinoma (iCCA) genomic findings with high versus low tumor mutational burdens

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy

Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial

Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial

A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

External control arms in oncology: current use and future directions

Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study

44P Investigation of scorpion venom-derived anticancer peptides inhibition of metastatic cancer cells growth and induction of apoptosis

Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial

585P Fragmentomics early detection assay leading to potential clinical benefits in colorectal cancer

Short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): A planned interim analysis

216P PTCH1 mutation as a potential predictor of immune checkpoint inhibitors in gastrointestinal cancer

246P DNA repair protein RAD51 homolog 1 (RAD51), a potential prognostic biomarker and target for breast cancer

Circular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s

1385P Phase II study of neoadjuvant camrelizumab combined with chemoradiation for locally advanced proximal gastric cancer (Neo-PLANET, NCT03631615)

5P Clinicopathologic features and genomic profiling of occult breast cancer

Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial

466P Integrated analysis of potential prognosis and differential expression between primary and metastatic foci for COL12A1 in breast cancer

Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies

Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

358P Anlotinib plus temozolomide for recurrent glioma: A single-center, retrospective study of 30 cases

Long-term results of postoperative chemoradiation therapy with capecitabine and oxaliplatin versus capecitabine alone for locally advanced rectal cancer: A randomized, multicenter, phase III trial

1337P Real-world utilization and outcomes of dacomitinib as first-line therapy in Asian patients with advanced EGFR mutation–positive NSCLC: An interim analysis of the ARIA study

Aktive Filter

Suchergebnisse filtern